Creso Pharma (ASX:CPH) completes US dual listing

• Creso Pharma (CPH) is officially dual listed, after completing its listing on the US OTCQB stock exchange
• The cannabis business will commence trading on the US market on today (Friday, June 11) under the ticker code COPHF
• CPH says its new listing will better expose the company to North American investors, ahead of its US pharmaceutical market entry
• The company is in the process of acquiring Halucenex, a Canadian business that is involved in researching psychedelics

Read the Full Article on The Market Herald here